↓ Skip to main content

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Overview of attention for article published in Breast Cancer Research and Treatment, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
44 Mendeley